With the Department of Government Efficiency (DOGE) set to work with agencies to cut rules that are not explicitly authorized by law, the College of American Pathologists (CAP) is pushing FDA’s laboratory-developed test (LDT) rule as an example of regulation the Trump administration should roll back as part of its deregulatory agenda.
For the full article click here: CAP: Trump’s Deregulatory Agenda Should Target LDT Rule